{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T18:20:55Z","timestamp":1780597255353,"version":"3.54.1"},"reference-count":126,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Biological Therapy"],"published-print":{"date-parts":[[2001,9]]},"DOI":"10.1517\/14712598.1.5.817","type":"journal-article","created":{"date-parts":[[2005,5,4]],"date-time":"2005-05-04T11:25:45Z","timestamp":1115205945000},"page":"817-829","source":"Crossref","is-referenced-by-count":102,"title":["Anticytokine therapy for osteoarthritis"],"prefix":"10.1517","volume":"1","author":[{"given":"Mary B","family":"Goldring","sequence":"first","affiliation":[{"name":"Beth Israel Deaconess Medical Center, Harvard Institutes of Medicine, HIM246, 4 Blackfan Circle, Boston, MA 02115-5713, USA. mgoldrin@bidmc.harvard.edu"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2005,2,23]]},"reference":[{"key":"e_1_2_1_3_1","first-page":"760","article-title":"Aging and osteoarthritis: basic mechanisms","volume":"41","author":"HAMERMAN D","year":"1993","unstructured":"HAMERMAN D: Aging and osteoarthritis: basic mechanisms. J. Am. Cedar Soc. (1993) 41:760\u2013770.","journal-title":"J. Am. Cedar Soc."},{"key":"e_1_2_1_4_1","first-page":"1969\u2013","article-title":"MARTEL-PELLETIER J, HOWELL DS: Etiopathogenesis of osteoarthritis. In: Arthritis and Allied Conditions: A Textbook of Rheumatology Koopman WJ (Ed","volume":"1997","author":"PELLETIER J-P,","year":"1984","unstructured":"PELLETIER J-P, MARTEL-PELLETIER J, HOWELL DS: Etiopathogenesis of osteoarthritis. In: Arthritis and Allied Conditions: A Textbook of Rheumatology Koopman WJ (Ed.), Williams and Wilkins, Baltimore (1997):1969\u20131984.","journal-title":"Williams and Wilkins, Baltimore"},{"key":"e_1_2_1_5_1","unstructured":"POOLE AR: Cartilage in Health and Disease. In: Arthritis am Allied Conditions: A Textbook of Rheumatology Koopman WJ (Ed.) Williams and Wilkins Baltimore (1997):255\u2013308."},{"key":"e_1_2_1_6_1","first-page":"107","article-title":"Articular cartilage and changes in arthritis","volume":"3","author":"SANDELL LJ","year":"2001","unstructured":"SANDELL LJ, AIGNER T: Articular cartilage and changes in arthritis. An introduction: cell Biology of osteoarthritis. Arthritis Res. (2001) 3:107\u2013113.","journal-title":"An introduction: cell Biology of osteoarthritis. Arthritis Res."},{"key":"e_1_2_1_7_1","first-page":"273","article-title":"Recent developments in the treatment of osteoarthritis","volume":"4","author":"CHIKANZA IC","year":"1999","unstructured":"CHIKANZA IC, FERNANDES L: Recent developments in the treatment of osteoarthritis. Expert Opirr. Investig. Drugs (1999) 4:273\u2013290.","journal-title":"Expert Opirr. Investig. Drugs"},{"key":"e_1_2_1_8_1","doi-asserted-by":"crossref","unstructured":"FELSON DT LAWRENCE RC HOCHBERG MC et al.: Osteoarthritis: new insights. Part 2: treatment approaches. Ann. Intern. Med. (2000) 133:726\u2013737.","DOI":"10.7326\/0003-4819-133-9-200011070-00015"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-000-0020-z"},{"key":"e_1_2_1_10_1","doi-asserted-by":"crossref","unstructured":"TIVE L: Celecoxib clinical profile. Rheumatol. (2000) 39\\(Suppl. 2):21\u201328.","DOI":"10.1093\/rheumatology\/39.suppl_2.21"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.1080\/030097401750065265"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-000-0023-9"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)03610-2"},{"key":"e_1_2_1_14_1","first-page":"663","article-title":"Oral glucosamine enhances chondroitin sulfate levels in articular cartilage after a chymopapain injury","volume":"26","author":"OEGEMA TRJ, DELORIA LB, HART DA","year":"2001","unstructured":"OEGEMA TRJ, DELORIA LB, HART DA: Oral glucosamine enhances chondroitin sulfate levels in articular cartilage after a chymopapain injury. Orthopaed. Trans.(2001) 26:663.","journal-title":"Orthopaed. Trans."},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.2741\/Poole"},{"key":"e_1_2_1_16_1","unstructured":"\u2022This recent review and other papers in this volume provide an excellent overview of the field and may be read online at http:\/\/ www.bioscience.org\/ 191999\/v4\/d."},{"key":"e_1_2_1_17_1","unstructured":"THONAR EJ-M LENZ ME MASUDA K MANICOURT D-H: Body fluid markers of cartilage metabolism. In: Dynamics of bone and cartilage metabolism. Seibel MJ Robins SP Bilezekian JP (Eds.) Academic Press New York (1999):453\u2013464."},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200005)43:5<953::AID-ANR1>3.0.CO;2-Q"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1053\/joca.1999.0288"},{"key":"e_1_2_1_20_1","doi-asserted-by":"crossref","unstructured":"POOLE AR: NIH white paper: Biomarkers the osteoarthritis initiative. (2000).","DOI":"10.1007\/978-1-59259-018-6_25"},{"key":"e_1_2_1_21_1","unstructured":"\u2022\u2022This is part of the report from theOsteoarthritis Initative Steering Group held on February 28\u201329 2000 at the NIH which may be read online at http:\/\/ www.nih.goviniams\/news\/oisg\/."},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1053\/joca.2000.0387"},{"key":"e_1_2_1_23_1","first-page":"1327","article-title":"Degenerative joint disease in the guinea pig","volume":"39","author":"WATSON PJ","year":"1996","unstructured":"WATSON PJ, HALL LD, MALCOLM A, TYLER JA: Degenerative joint disease in the guinea pig. Use of magnetic resonance imaging to monitor progression of bone pathology. Arthritis Rheum. (1996) 39:1327\u20131337.","journal-title":"Use of magnetic resonance imaging to monitor progression of bone pathology. Arthritis Rheum."},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004424-200010000-00008"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200103)44:3<585::AID-ANR107>3.0.CO;2-C"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.2741\/Homandberg"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.3109\/03008209909005273"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200009)43:9<1916::AID-ANR2>3.0.CO;2-I"},{"key":"e_1_2_1_29_1","unstructured":"DINARELLO CA MOLDAWER LL: Proinflammatory and anti-inflammatory cytokines in rheumatoid arthritis: a primer for clinicians. Amgen Inc. Thousand Oaks CA (2000)."},{"key":"e_1_2_1_30_1","unstructured":"\u2022\u2022This excellent compendium and otherresources on the role of cytokines in arthritis may be ordered online at www.interleultin-1.com."},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1053\/joca.1998.0224"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200101)44:1<105::AID-ANR14>3.0.CO;2-3"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1359-6101(98)00018-5"},{"key":"e_1_2_1_34_1","unstructured":"\u2022Excellent review of structure-function relationships of IL-1 ligands and receptors."},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118045"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.16.1.27"},{"key":"e_1_2_1_37_1","unstructured":"\u2022\u2022Review of IL-1Ra structure and function."},{"key":"e_1_2_1_38_1","doi-asserted-by":"publisher","DOI":"10.1053\/joca.1999.0292"},{"key":"e_1_2_1_39_1","doi-asserted-by":"crossref","first-page":"4570","DOI":"10.4049\/jimmunol.160.9.4570","article-title":"TNF-a convertase enzyme from human arthritis-affected cartilage: isolation of cDNA by differential display, expression of the active enzyme, and regulation of TNF-a","volume":"160","author":"PATEL IR","year":"1998","unstructured":"PATEL IR, ATTUR MG, PATEL RN et al: TNF-a convertase enzyme from human arthritis-affected cartilage: isolation of cDNA by differential display, expression of the active enzyme, and regulation of TNF-a. J. Immune]. (1998) 160:4570\u20134579.","journal-title":"J. Immune]."},{"key":"e_1_2_1_40_1","doi-asserted-by":"crossref","unstructured":"FELDMAN M BONDESON J BRENNAN FM FOXWELL BMJ MAINI RN: The rationale for the current boom in anti-TNFa treatment. Is there an effective means to define therapeutic targets for drugs that provide all the benefits of anti-TNFa and minimize hazards? Ann. Rheum. Dis. (1999) 58 (Suppl. B:I27431.","DOI":"10.1136\/ard.58.2008.i27"},{"key":"e_1_2_1_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780200710"},{"key":"e_1_2_1_42_1","unstructured":"\u2022First report of IL-1 as a catabolic factor for cartilage."},{"key":"e_1_2_1_43_1","doi-asserted-by":"publisher","DOI":"10.1042\/bj1840177"},{"key":"e_1_2_1_44_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.188134"},{"key":"e_1_2_1_45_1","unstructured":"\u2022First report of IL-1 as inducer of metalloproteinase production by rheumatoid synovial fibroblasts."},{"key":"e_1_2_1_46_1","doi-asserted-by":"publisher","DOI":"10.1038\/286891a0"},{"key":"e_1_2_1_47_1","unstructured":"GOLDRING MB: Degradation of articular cartilage in culture: Regulatory factors. In: Joint Cartilage Degradation: Basic and Clinical Aspects. Woessner JF Jr. Howell DS (Eds.) Marcel Dekker Inc. New York (1993):281\u2013345."},{"key":"e_1_2_1_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-0172(96)80036-9"},{"key":"e_1_2_1_49_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-000-0019-5"},{"key":"e_1_2_1_50_1","doi-asserted-by":"crossref","unstructured":"ATTUR MG DAVE M CIPOLLETTA C etal.: Reversal of autocrine and paracrine effects of interleukin 1 (IL-1) in human arthritis by Type II IL-1 decoy receptor. Potential for pharmacological intervention. J. Biol. Chem. (2000) 275:40307\u201340315.","DOI":"10.1074\/jbc.M002721200"},{"key":"e_1_2_1_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-6749(99)70518-X"},{"key":"e_1_2_1_52_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI8731"},{"key":"e_1_2_1_53_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199908)42:8<1577::AID-ANR3>3.0.CO;2-Z"},{"key":"e_1_2_1_54_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E"},{"key":"e_1_2_1_55_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.273.42.27467"},{"key":"e_1_2_1_56_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.162.2.1096"},{"key":"e_1_2_1_57_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.59.7.529"},{"key":"e_1_2_1_58_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200006)43:6<1300::AID-ANR12>3.0.CO;2-D"},{"key":"e_1_2_1_59_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199904)42:4<710::AID-ANR14>3.0.CO;2-4"},{"key":"e_1_2_1_60_1","first-page":"155","article-title":"MEYER ZUM BUSCHENFELDE KH, MARKER-HERMANN E: Different cytokine profiles in the synovial fluid of patients with osteoarthritis, rheumatoid arthritis and seronegative spondylarthropathies","volume":"14","author":"SCHLAAK JF","year":"1996","unstructured":"SCHLAAK JF, PFERS I, MEYER ZUM BUSCHENFELDE KH, MARKER-HERMANN E: Different cytokine profiles in the synovial fluid of patients with osteoarthritis, rheumatoid arthritis and seronegative spondylarthropathies. Gun. Exp. Rheumatol. (1996) 14:155\u2013162.","journal-title":"Gun. Exp. Rheumatol."},{"key":"e_1_2_1_61_1","doi-asserted-by":"publisher","DOI":"10.1006\/clin.1997.4441"},{"key":"e_1_2_1_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9120(98)00062-9"},{"key":"e_1_2_1_63_1","first-page":"870","article-title":"Immunohistological analysis of cytokine expression in human osteoarthritic and healthy cartilage","volume":"26","author":"MOOS V","year":"1999","unstructured":"MOOS V, FICKERT S, MULLER B, WEBER U, SIEPER J: Immunohistological analysis of cytokine expression in human osteoarthritic and healthy cartilage. Rheumatol. (1999) 26:870\u2013879.","journal-title":"Rheumatol."},{"key":"e_1_2_1_64_1","doi-asserted-by":"publisher","DOI":"10.1006\/cyto.1999.0505"},{"key":"e_1_2_1_65_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar94"},{"key":"e_1_2_1_66_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar133"},{"key":"e_1_2_1_67_1","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.1999.14.11.1805"},{"key":"e_1_2_1_68_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar136"},{"key":"e_1_2_1_69_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780400604"},{"key":"e_1_2_1_70_1","doi-asserted-by":"crossref","unstructured":"CARON JP FERNANDES JC MARTEL-PELLETIER J et al.: Chondroprotective effect of intraarticular injections ofinterleukin-1 receptor antagonist in experimental osteoarthritis. Suppression of collagenase-1 expression. Arthritis Rheum. (1996) 39:1535\u20131544.","DOI":"10.1002\/art.1780390914"},{"key":"e_1_2_1_71_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002281-199705000-00008"},{"key":"e_1_2_1_72_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.93.20.11008"},{"key":"e_1_2_1_73_1","first-page":"313","article-title":"Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice","volume":"191","author":"HORAI R","year":"2000","unstructured":"HORAI R, SAIJO S, TANIOKA J et al.: Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. j Esp. Med. (2000) 191:313\u2013320.","journal-title":"j Esp. Med."},{"key":"e_1_2_1_74_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.163.9.5049"},{"key":"e_1_2_1_75_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200012)43:12<2648::AID-ANR4>3.0.CO;2-M"},{"key":"e_1_2_1_76_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780390318"},{"key":"e_1_2_1_77_1","doi-asserted-by":"crossref","unstructured":"LUBBERTS E JOOSTEN LA VAN DEN BERSSELAAR L et al.: Adenoviral vector-mediated overexpression of IL-4 in the knee joint of mice with collagen-induced arthritis prevents cartilage destruction. j Immunol. (1999) 163:4546\u20134556.","DOI":"10.4049\/jimmunol.163.8.4546"},{"key":"e_1_2_1_78_1","doi-asserted-by":"crossref","unstructured":"LUBBERTS E JOOSTEN LA VAN DEN BERSSELAAR L et al.: Intra-articular IL-10 gene transfer regulates the expression of collagen-induced arthritis (CIA) in the knee and ipsilateral paw. Clin. Esp. Immunol. (2000) 120:375\u2013383.","DOI":"10.1046\/j.1365-2249.2000.01217.x"},{"key":"e_1_2_1_79_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200101)44:1<3::AID-ANR2>3.0.CO;2-U"},{"key":"e_1_2_1_80_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2567.1998.00568.x"},{"key":"e_1_2_1_81_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199904)42:3<490::AID-ANR14>3.0.CO;2-L"},{"key":"e_1_2_1_82_1","doi-asserted-by":"crossref","unstructured":"WHALEN JD LECHMAN EL CARLOS CA etal.: Adenoviral transfer of the viral IL-10 gene periarticularly to mouse paws suppresses development of collagen-induced arthritis in both injected and uninjected paws. j Immunol. (1999) 162:3625\u20133632.","DOI":"10.4049\/jimmunol.162.6.3625"},{"key":"e_1_2_1_83_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.163.4.2202"},{"key":"e_1_2_1_84_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200006)43:6<1290::AID-ANR11>3.0.CO;2-R"},{"key":"e_1_2_1_85_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.275.21.16007"},{"key":"e_1_2_1_86_1","unstructured":"HENROTIN YE ZHENG SX DEBY GP etal.: Nitric oxide downregulates interleukin lbetalbeta) stimulated IL-6 IL-8 and prostaglandin E2 production by human chondrocytes. I Rheumatol. (1998) 25:1595\u20131601."},{"key":"e_1_2_1_87_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.9.7.1469"},{"key":"e_1_2_1_88_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200003)43:3<673::AID-ANR25>3.0.CO;2-8"},{"key":"e_1_2_1_89_1","unstructured":"\u2022This paper demonstrates the use of selective MMP inhibitors and epitope- specific antibodies for analysing mechanisms of OA cartilage degradation."},{"key":"e_1_2_1_90_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200105)44:5<1096::AID-ANR190>3.0.CO;2-6"},{"key":"e_1_2_1_91_1","doi-asserted-by":"crossref","unstructured":"NEUHOLD LA KILLAR L ZHAO W et al.: Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice. 1. Chi]. Invest. (2001) 107:35\u201344.","DOI":"10.1172\/JCI10564"},{"key":"e_1_2_1_92_1","unstructured":"\u2022\u2022First demonstration in vivo of the criticalrole of MMP-13 in osteoarthritis."},{"key":"e_1_2_1_93_1","first-page":"1664","article-title":"Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins","volume":"1999","author":"TORTORELLA MD","unstructured":"TORTORELLA MD, BURN TC, PRATTA MA et al.: Purification and cloning of aggrecanase-1: a member of the ADAMTS family of proteins. Science (1999) 284: 1664-1666.","journal-title":"Science"},{"key":"e_1_2_1_94_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.33.23443"},{"key":"e_1_2_1_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1367-5931(99)80071-4"},{"key":"e_1_2_1_96_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200001)43:1<175::AID-ANR22>3.0.CO;2-S"},{"key":"e_1_2_1_97_1","doi-asserted-by":"crossref","unstructured":"FOXWELL BMJ BONDESON J BRENNAN E FELDMANN M: Adenoviral transgene delivery provides an approach to indentifying important molecular processes in inflammation: evidence for heterogenecity in the requirement for NFicB in tumour necrosis factor production. Ann. Rheum. Dis. (2000) 59(Suppl.","DOI":"10.1136\/ard.59.suppl_1.i54"},{"key":"e_1_2_1_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1357-4310(00)01814-1"},{"key":"e_1_2_1_99_1","unstructured":"EVANS CH ROBBINS PD"},{"key":"e_1_2_1_100_1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.1996.7.10-1261"},{"key":"e_1_2_1_101_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199901)42:1<1::AID-ANR1>3.0.CO;2-4"},{"key":"e_1_2_1_102_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.51.1.207"},{"key":"e_1_2_1_103_1","unstructured":"\u2022\u2022Up-to-date and comprehensive review ofanti-cytokine therapy for rheumatoid arthritis."},{"key":"e_1_2_1_104_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200012)43:12<2619::AID-ANR1>3.0.CO;2-V"},{"key":"e_1_2_1_105_1","doi-asserted-by":"crossref","unstructured":"CAMPION GV LEBSACK ME LOOKABAUGH J GORDON G CATALANO M: Dose-range and dose-frequency study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis. The IL-1Ra Arthritis Study Group. Arthritis Rheum. (1996) 39:1092\u20131101.","DOI":"10.1002\/art.1780390704"},{"key":"e_1_2_1_106_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199812)41:12<2196::AID-ART15>3.0.CO;2-2"},{"key":"e_1_2_1_107_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200005)43:5<1001::AID-ANR7>3.0.CO;2-P"},{"key":"e_1_2_1_108_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780390212"},{"key":"e_1_2_1_109_1","doi-asserted-by":"crossref","unstructured":"AREND WP MALYAK M SMITH ME JR. et al.: Binding of IL-1 alpha IL-1 beta and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids. 1. Immurrof (1994) 153:4766\u20134774.","DOI":"10.4049\/jimmunol.153.10.4766"},{"key":"e_1_2_1_110_1","doi-asserted-by":"crossref","unstructured":"VAN DEN BERG WB: Arguments for interleukin 1 as a target in chronic arthritis. Ann. Rheum. Dis. (2000) 59\\(Suppl. 1):i81\u2013","DOI":"10.1136\/ard.59.suppl_1.i81"},{"key":"e_1_2_1_111_1","unstructured":"\u2022\u2022Van den Berg provides a persuasiveargument for the critical role of IL-1 in cartilage erosion."},{"key":"e_1_2_1_112_1","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.8.4.383"},{"key":"e_1_2_1_113_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.2042-3306.1999.tb03799.x"},{"key":"e_1_2_1_114_1","doi-asserted-by":"publisher","DOI":"10.1053\/joca.1998.0181"},{"key":"e_1_2_1_115_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199707)40:7<1282::AID-ART13>3.0.CO;2-E"},{"key":"e_1_2_1_116_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar134"},{"key":"e_1_2_1_117_1","unstructured":"\u2022\u2022Timely review of signalling by TNF-receptor family members including RANKL and their role in bone resorption."},{"key":"e_1_2_1_118_1","first-page":"304","volume":"402","author":"KONG YY","year":"1999","unstructured":"KONG YY, FEIGE U, SAROSI I etal.: Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature (1999) 402:304\u2013309.","journal-title":"SAROSI I etal.: Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature"},{"key":"e_1_2_1_119_1","unstructured":"KOMURO H OLEE T QUACH J et al.: The RANK\/RANKUOPG system in cartilage. Osteoarthritis Cartilage (2000) 8(Suppl.R537."},{"key":"e_1_2_1_120_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar81"},{"key":"e_1_2_1_121_1","unstructured":"EVANS CH ROBBINS PD GHIVIZZANI SC et al.: Results from the first human clinical trial of gene therapy for arthritis. Arthritis Rheum. (1999) 44(Suppl.):S170."},{"key":"e_1_2_1_122_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780400518"},{"key":"e_1_2_1_123_1","doi-asserted-by":"crossref","unstructured":"GHIVIZZANI SC LECHMAN ER KANG R etal.: Direct adenovirus-mediated gene transfer of interleukin 1 and tumor necrosis factor a soluble receptors to rabbit knees with experimental arthritis has local and distal anti-arthritic effects. Proc. Nati Acad. Sri. USA (1998) 95:4613\u20134618.","DOI":"10.1073\/pnas.95.8.4613"},{"key":"e_1_2_1_124_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar104"},{"key":"e_1_2_1_125_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-857X(05)70071-5"},{"key":"e_1_2_1_126_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200005)43:5<1156::AID-ANR26>3.0.CO;2-M"},{"key":"e_1_2_1_127_1","doi-asserted-by":"publisher","DOI":"10.1002\/jor.1100170209"},{"key":"e_1_2_1_128_1","first-page":"1745","article-title":"00 JU, BARTHEL TS, NISHIMURA K, SOLCHAGA L, CAPLAN AT, GOLDBERG VM, JOHNSTONE B: The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells","volume":"80","author":"Y","year":"1998","unstructured":"Y00 JU, BARTHEL TS, NISHIMURA K, SOLCHAGA L, CAPLAN AT, GOLDBERG VM, JOHNSTONE B: The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells. J. Boric...Joint Sorg. -Am. (1998) 80:1745\u20131757.","journal-title":"J. Boric...Joint Sorg. -Am."}],"container-title":["Expert Opinion on Biological Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14712598.1.5.817","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T16:50:55Z","timestamp":1772729455000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14712598.1.5.817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9]]},"references-count":126,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2001,9]]}},"alternative-id":["10.1517\/14712598.1.5.817"],"URL":"https:\/\/doi.org\/10.1517\/14712598.1.5.817","relation":{},"ISSN":["1471-2598","1744-7682"],"issn-type":[{"value":"1471-2598","type":"print"},{"value":"1744-7682","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,9]]}}}